• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed

    2/16/21 11:05:09 AM ET
    $LMNX
    Medical/Dental Instruments
    Health Care
    Get the next $LMNX alert in real time by email
    SC 13G/A 1 LMNX-13GA3-2020.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Amendment No. 3)* Under the Securities Exchange Act of 1934 LUMINEX CORPORATION ----------------------------------------------------------------------------- (Name of Issuer) Common Stock, par value $0.001 per share ----------------------------------------------------------------------------- (Title of Class of Securities) 55027E102 ----------------------------------------------------------------------------- (CUSIP Number) December 31, 2020 ----------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [_] Rule 13d-1(c) [_] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). ============================================================================= ----------------------------------------------------------------------------- CUSIP NO. 55027E102 13G ----------------------------------------------------------------------------- (1) NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only). RGM Capital, LLC 06-16885711 ----------------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): (a) [_] (b) [_] ----------------------------------------------------------------------------- (3) SEC USE ONLY ----------------------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION Delaware ----------------------------------------------------------------------------- (5) SOLE VOTING POWER NUMBER OF SHARES 0 BENEFICIALLY OWNED _____________________________ BY EACH REPORTING PERSON WITH: (6) SHARED VOTING POWER 2,703,199 _____________________________ (7) SOLE DISPOSITIVE POWER 0 _____________________________ (8) SHARED DISPOSITIVE POWER 2,703,199 ______________________________ (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,703,199 ------------------------------------------------------------------------------ (10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] ------------------------------------------------------------------------------ (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.81 % ------------------------------------------------------------------------------ (12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IA ============================================================================= ----------------------------------------------------------------------------- CUSIP NO. 55027E102 13G ----------------------------------------------------------------------------- (1) NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). Robert G. Moses ----------------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [_] ----------------------------------------------------------------------------- (3) SEC USE ONLY ----------------------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION United States ----------------------------------------------------------------------------- (5) SOLE VOTING POWER NUMBER OF SHARES 0 BENEFICIALLY OWNED _____________________________ BY EACH REPORTING PERSON WITH: (6) SHARED VOTING POWER 2,703,199 _____________________________ (7) SOLE DISPOSITIVE POWER 0 _____________________________ (8) SHARED DISPOSITIVE POWER 2,703,199 ______________________________ (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,703,199 ------------------------------------------------------------------------------ (10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] ------------------------------------------------------------------------------ (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.81 % ------------------------------------------------------------------------------ (12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) HC ============================================================================= ----------------------------------------------------------------------------- CUSIP NO. 55027E102 13G ----------------------------------------------------------------------------- Item 1. (a) Name of Issuer LUMINEX CORPORATION (b) Address of Issuer's Principal Executive Offices. 12212 Technology Blvd., Austin, TX 78727 Item 2. (a) Name of Person Filing. Robert G. Moses RGM Capital, LLC (b) Address of Principal Business Office, or if None, Residence. 9010 Strada Stell Court, Suite 105, Naples, FL 34109 (c) Citizenship. United States (d) Title of Class of Securities. Common Stock, par value $0.001 per share (e) CUSIP Number. 55027E102 Item 3. If this statement is filed pursuant to Rule 13d-1(b) or 13-d-2(b) or (c),check whether the person filing is a: (a) [_] Broker or dealer registered under section 15 of the Act. (b) [_] Bank as defined in section 3(a)(6) of the Act. (c) [_] Insurance Company as defined in section 3(a)(19) of the Act. (d) [_] Investment Company registered under section 8 of the Investment Company Act. (e) [x] Investment Adviser in accordance with Sec.240.13d-1(b)(1)(ii)(E). (f) [_] Employee Benefit Plan or Endowment Fund in accordance with Sec. 240.13d-1(b)(1)(ii)(F). (g) [x] Parent holding company or control person, in accordance with Sec.240.13d-1(b)(1)(ii)(G). (h) [_] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act. (i) [_] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940. (j) [_] Group, in accordance with Sec.240.13d-1(b)(1)(ii)(J). Item 4. Ownership. (a) Amount beneficially owned. 2,703,199 (b) Percent of class. 5.81 % (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote 0 -------------------- (ii) Shared power to vote or to direct the vote 2,703,199 -------------------- (iii) Sole power to dispose or to direct the disposition of 0 -------------------- (iv) Shared power to dispose or to direct the disposition of 2,703,199 -------------------- Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [ ] Item 6. Ownership of More Than Five Percent on Behalf of Another Person. Robert G. Moses is the managing member of RGM Capital, LLC, a Delaware limited liability company that serves as investment adviser to, and exercises investment discretion over, a number of investment accounts and investment vehicles. None of those investment accounts or investment vehicles has beneficial ownership of 5% or more of any class of the Common Stock. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not applicable Item 8. Identification and Classification of Members of the Group. Not applicable Item 9. Notice of Dissolution of a Group. Not applicable Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 12, 2021 RGM CAPITAL, LLC* By: /s/ Robert G. Moses --------------------------- Name: Robert G. Moses Title: Managing Member Robert G. Moses* By: /s/ Robert G. Moses --------------------------- * The Reporting Persons disclaim beneficial ownership of the shares reported herein except to the extent of their pecuniary interest. EXHIBIT INDEX EXHIBIT B: Joint Acquisition Statement Pursuant to Section 240.13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him, her or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other entities or persons, except to the extent that he, she or it knows or has reason to believe that such information is inaccurate. Date: February 12, 2021 RGM CAPITAL, LLC By: /s/ Robert G. Moses --------------------------- Name: Robert G. Moses Title: Managing Member Robert G. Moses By: /s/ Robert G. Moses ---------------------------
    Get the next $LMNX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LMNX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LMNX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Luminex downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Luminex from Overweight to Neutral and set a new price target of $37.00 from $38.00 previously

    4/13/21 11:58:03 AM ET
    $LMNX
    Medical/Dental Instruments
    Health Care

    Luminex downgraded by BTIG

    BTIG downgraded Luminex from Buy to Neutral

    4/13/21 7:45:27 AM ET
    $LMNX
    Medical/Dental Instruments
    Health Care

    $LMNX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Middlesex Water Set to Join S&P SmallCap 600

    NEW YORK, July 12, 2021 /PRNewswire/ -- Middlesex Water Co. (NASD: MSEX) will replace Luminex Corp. (NASD: LMNX) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, July 15. DiaSorin S.p.A. is acquiring Luminex in a deal expected to be completed soon pending final closing conditions. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector July 15, 2021 S&P SmallCap 600 Addition Middlesex Water MSEX Utilities S&P SmallCap 600 Deletion Luminex LMNX Health Care For more information about S&P Dow Jones Indices, please visit www.spdji.com. ABOUT

    7/12/21 6:26:00 PM ET
    $SPGI
    $MSEX
    $LMNX
    Finance: Consumer Services
    Finance
    Water Supply
    Utilities

    Luminex Corporation Declares Second Quarter Cash Dividend

    AUSTIN, Texas, May 20, 2021 /PRNewswire/ -- Luminex Corporation (NASDAQ:LMNX) (the "Company") today announced that its board of directors declared a cash dividend for the second quarter of 2021 of $0.10 per share of common stock payable on July 8, 2021 to stockholders of record as of the close of business June 17, 2021. About Luminex CorporationAt Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health.  We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical

    5/20/21 4:30:00 PM ET
    $LMNX
    Medical/Dental Instruments
    Health Care

    DiaSorin to acquire Luminex Corporation for USD 37.00 per share or approximately USD 1.8 billion

    SALUGGIA, Italy, April 11, 2021 /PRNewswire/ -- DiaSorin S.p.A. ("DiaSorin"; FTSE MIB: DIA) today announced that its Board of Directors has unanimously approved and signed a definitive merger agreement for DiaSorin to acquire Luminex Corporation ((", Luminex", , NASDAQ:LMNX) for a price of USD 37.00 per share in an all-cash transaction. This corresponds to a total equity value of approximately USD 1.8 billion on a fully diluted basis and an enterprise value of approximately USD 1.8 billion. The cash consideration represents a c.23.1% premium to Luminex shareholders based on the unaffected closing stock price of Luminex on 24 February 2021 (the date prior to press rumors regarding a potentia

    4/12/21 10:51:00 AM ET
    $LMNX
    Medical/Dental Instruments
    Health Care

    $LMNX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Lewis Dijuana K returned $257,335 worth of Common Stock to the company (6,955 units at $37.00) , closing all direct ownership in the company

    4 - LUMINEX CORP (0001033905) (Issuer)

    7/15/21 4:02:22 PM ET
    $LMNX
    Medical/Dental Instruments
    Health Care

    SEC Form 4: MCNAMARA KEVIN M returned $3,713,616 worth of Common Stock to the company (100,368 units at $37.00) , closing all direct ownership in the company to cover withholding tax

    4 - LUMINEX CORP (0001033905) (Issuer)

    7/15/21 4:02:50 PM ET
    $LMNX
    Medical/Dental Instruments
    Health Care

    SEC Form 4: SAMET KENNETH A returned $733,229 worth of Common Stock to the company (19,817 units at $37.00) , closing all direct ownership in the company (withholding tax)

    4 - LUMINEX CORP (0001033905) (Issuer)

    7/15/21 4:03:40 PM ET
    $LMNX
    Medical/Dental Instruments
    Health Care

    $LMNX
    SEC Filings

    View All

    SEC Form 15-12G filed by Luminex Corporation

    15-12G - LUMINEX CORP (0001033905) (Filer)

    7/26/21 4:11:53 PM ET
    $LMNX
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 POS filed by Luminex Corporation

    S-8 POS - LUMINEX CORP (0001033905) (Filer)

    7/14/21 9:27:28 AM ET
    $LMNX
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 POS filed by Luminex Corporation

    S-8 POS - LUMINEX CORP (0001033905) (Filer)

    7/14/21 9:24:58 AM ET
    $LMNX
    Medical/Dental Instruments
    Health Care

    $LMNX
    Financials

    Live finance-specific insights

    View All

    Luminex Corporation Declares Second Quarter Cash Dividend

    AUSTIN, Texas, May 20, 2021 /PRNewswire/ -- Luminex Corporation (NASDAQ:LMNX) (the "Company") today announced that its board of directors declared a cash dividend for the second quarter of 2021 of $0.10 per share of common stock payable on July 8, 2021 to stockholders of record as of the close of business June 17, 2021. About Luminex CorporationAt Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health.  We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical

    5/20/21 4:30:00 PM ET
    $LMNX
    Medical/Dental Instruments
    Health Care

    Luminex Corporation Reports Fourth Quarter and Full-Year 2020 Results

    AUSTIN, Texas, Feb. 8, 2021 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced results for its fourth quarter and full-year ended December 31, 2020. All amounts in this release are in conformity with U.S. generally accepted accounting principles ("GAAP"). CURRENT FINANCIAL HIGHLIGHTS Record revenue for the fourth quarter of $111.4M, a 23% increase over Q4 2019, and record revenue for the year of $417.4M, up 25% vs. 2019, driven primarily by growth associated with the COVID-19 global pandemic Gross margins of 58% for the quarter and 59% for the full year, an improvement of 3 and 4 percentage points, respectively, vs. Q4 and full-year 2019 Operating margin of $10.5M or 9

    2/8/21 4:01:00 PM ET
    $LMNX
    Medical/Dental Instruments
    Health Care

    Luminex Corporation Declares First Quarter Cash Dividend

    AUSTIN, Texas, Feb. 8, 2021 /PRNewswire/ -- Luminex Corporation (Nasdaq:LMNX) (the "Company") today announced that its board of directors declared a cash dividend for the first quarter of 2021 of $0.10 per share of common stock payable on April 15, 2021 to stockholders of record as of the close of business March 25, 2021. About Luminex CorporationAt Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health.  We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We a

    2/8/21 1:00:00 PM ET
    $LMNX
    Medical/Dental Instruments
    Health Care

    $LMNX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed

    SC 13G/A - LUMINEX CORP (0001033905) (Subject)

    2/16/21 11:05:09 AM ET
    $LMNX
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed

    SC 13G/A - LUMINEX CORP (0001033905) (Subject)

    2/10/21 11:22:44 AM ET
    $LMNX
    Medical/Dental Instruments
    Health Care